NCT00787527
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,977 public trials
2,028 recruiting studies
Immunoproliferative Disorders trial results
NCT01609010
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Copenhagen, Denmark
- Hillerød, Denmark
- Roskilde, Denmark
- Bergen, Norway
NCT00445731
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
- Locations
-
Not specified
NCT01689220
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +91 more
- Locations
-
- Chedoke-McMaster Hospitals Hamilton, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
NCT01309334
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Bordeaux University Hospital Bordeaux, France
- Brest University Hospital "CHU du Morvan" Brest, France
- Hospital "Côte de Nacre" Caen, France
- Clermont-Ferrand University Hospital Clermont-Ferrand, France
NCT00920738
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +49 more
- Locations
-
- University of Minnesota Children's Hospital - Fairview Minneapolis, Minnesota, United States
NCT01499303
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Research Site Huntsville, Alabama, United States
- Research Site Denver, Colorado, United States
- Research Site New Haven, Connecticut, United States
- Research Site Sarasota, Florida, United States
NCT00583323
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
Not specified
Completed
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
NCT00854568
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China